[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kajiyama et al., 2000 - Google Patents

Elevated levels of serum sulfite in patients with chronic renal failure

Kajiyama et al., 2000

Document ID
4233549737951515005
Author
Kajiyama H
Nojima Y
Mitsuhashi H
Ueki K
Tamura S
Sekihara T
Wakamatsu R
Yano S
Naruse T
Publication year
Publication venue
Journal of the American Society of Nephrology

External Links

Snippet

Sulfite, a well known air pollutant, is toxic for humans, especially those with sulfite hypersensitivity. Sulfite is also generated endogenously, during normal metabolism of sulfur- containing amino acids. Mammalian tissues contain the enzyme sulfite oxidase, which …
Continue reading at journals.lww.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders

Similar Documents

Publication Publication Date Title
Kajiyama et al. Elevated levels of serum sulfite in patients with chronic renal failure
Himmelfarb et al. Oxidative stress is increased in critically ill patients with acute renal failure
Doughty et al. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure
Konrad et al. γ-Glutamyl-cysteine synthetase deficiency: A cause of hereditary hemolytic anemia
Mitsuhashi et al. Increased levels of serum sulfite in patients with acute pneumonia
Cooper et al. Role of the spleen in membrane conditioning and hemolysis of spur cells in liver disease
Kandouz et al. Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration
Túri et al. Oxidative stress and antioxidant defense mechanism in glomerular diseases
Angstwurm et al. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome
Bonomini et al. Increased erythrocyte phosphatidylserine exposure in chronic renal failure
Raff et al. New insights into uremic toxicity
Usberti et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients
Luo et al. HCO 3− salvage mechanisms in the submandibular gland acinar and duct cells
Hakim et al. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis
Sadowska-Bartosz et al. Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections
Georgatzakou et al. Red blood cell abnormalities and the pathogenesis of anemia in end‐stage renal disease
Mueller et al. Novel insights into alcoholic liver disease: Iron overload, iron sensing and hemolysis
Ilcol et al. Endotoxin alters serum-free choline and phospholipid-bound choline concentrations, and choline administration attenuates endotoxin-induced organ injury in dogs
Dockham et al. Relative contribution of human erythrocyte aldehyde dehydrogenase to the systemic detoxification of the oxazaphosphorines
Pinkney et al. Endothelial dysfunction in Type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin E
Alli et al. Chronic ethanol exposure alters the lung proteome and leads to mitochondrial dysfunction in alveolar type 2 cells
Calkins et al. Effect of high‐dose cysteine supplementation on erythrocyte glutathione: A double‐blinded, randomized placebo‐controlled pilot study in critically ill neonates
Lespier-Dexter et al. Granulocyte adherence in uremia and hemodialysis
Van De Casteele et al. Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself
Bandara et al. Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C